Dehydroepiandrosterone (DHEA), a popular supplement among athletes, does not increase testosterone levels and may, in fact, break down into hormones associated with prostate gland growth, according to results of a small study from the Keck School of Medicine at the University of Southern California, Los Angeles.
Prostate cancer genomic tests show prognostic value for progression, therapy benefit
April 22nd 2024"This preplanned ENACT trial biomarker analysis demonstrates the value of the Decipher score, AR-A score, and PAM50 genomic classifiers in identifying patients undergoing AS who are most likely to benefit from enzalutamide treatment," wrote the authors.